Clinical Trials in Detroit

Showing 6461-6480 of 19,719 trials

Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy

NCT05248009

Consenting subjects will receive a semi-permanent tattoo in place of the standard of care permanent tattoo for radiation marking at the time of the radiation planning scan. Subjects will be monitored to ensure alignment is the same with the semi-permanent tattoo as the current standard of care. Subjects will be monitored to ensure there are no skin reactions or other side effects. Subjects will be followed for 15 months and will send pictures to the treatment team to ensure that the tattoo fades away within 12 months as expected.

Tattoo; PigmentationCancer, Treatment-Related

Henry Ford Health System15 participantsStarted Jun 2022

Detroit, Michigan, United States

COMPLETEDPhase 317 miles

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

NCT02783729

This study will be conducted to demonstrate, using polysomnography, that lemborexant 10 milligrams (mg) and 5 mg is superior to placebo on objective sleep onset as assessed by latency to persistent to sleep (LPS) after the last 2 nights of 1 month of treatment in participants 55 years and older with insomnia disorder.

Insomnia

Eisai Inc.1,006 participantsStarted May 2016

Jasper, Alabama, United States • Glendale, Arizona, United States • Little Rock, Arkansas, United States +99 more locations

Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Find Trials by Condition in Detroit

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Wound Assessment Using Spectral Imaging US

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

EnSite Precision Observational Study

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients